Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has the Cell & Gene Therapy Manufacturing Services Market Growth Performance Trended Historically, And What Lies Ahead?
The market size for cell & gene therapy manufacturing services has experienced swift expansion in the past few years. It is predicted to rise from $8.15 billion in 2024 to $9.44 billion in 2025, reflecting a compound annual growth rate (CAGR) of 15.9%. Factors contributing to the rapid escalation during the historical period include a surge in research and development investments, regulatory backing and frameworks, an expanding pipeline of cell & gene therapies, collaborative efforts within the industry, and a growing global appetite for personalized medicine.
In the coming years, rapid expansion is anticipated in the cell & gene therapy manufacturing services market; it’s projected to reach $17.92 billion in 2029 with a compound annual growth rate (CAGR) of 17.4%. This growth during the predicted period is due to factors such as market maturation and commercialization, the worldwide growth of biopharmaceutical manufacturing, increased outsourcing activities by pharmaceutical corporations, automation and robotics advancements, and the introduction of new therapeutic methods. Future trends, during the forecasted period, are expected to include an increased demand for energy efficiency, advanced materials and technologies, compact and modular designs, transportation electrification, and an emphasis on safety and reliability.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10035&type=smp
Which Factors and External Forces Are Driving Demand in the Cell & Gene Therapy Manufacturing Services Market?
The surge in cases of cancer and other targeted diseases is anticipated to fuel the expansion of the cell and gene therapy manufacturing services market in the future. Cancer, characterized by the quick and uncontrolled multiplication of body cells resulting in abnormal growth, is a serious ailment. The rising rate of cancer has given rise to the use of cell and gene therapies, which are emerging as promising new approaches. This has increased the demand for innovative and effective treatment options. For example, in January 2023, the American Cancer Society, a non-profit cancer advocacy organization based in the USA recorded an increase in cancer cases from 1,898,160 in 2021 to 1,958,310 in 2023, a growth rate of 3.16%. Hence, the upsurge in cases of cancer and other target diseases is anticipated to drive the expansion of the cell and gene therapy manufacturing services market moving ahead.
Which Segments in the Cell & Gene Therapy Manufacturing Services Offer the Most Growth?
The cell & gene therapy manufacturing servicesmarket covered in this report is segmented –
1) By Type: Gene Therapy; Cell Therapy
2) By Indication: Central Nervous System Disorders; Ophthalmology Diseases; Cardiovascular Diseases; Infectious Diseases; Orthopedic Diseases; Oncology Diseases
3) By Application: Commercial Manufacturing; Clinical Manufacturing
4) By End-user: Academic And Research Institutes; Pharmaceutical And Biotechnology Companies; Other End-Users
Subsegments:
1) By Gene Therapy: Viral Vector Manufacturing; Plasmid DNA Production; Gene Editing Services; Formulation And Fill-Finish Services
2) By Cell Therapy: Cell Sourcing And Banking; Cell Processing And Expansion; Quality Control And Testing Services; Cryopreservation And Storage Services
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=10035&type=smp
What Are the Fastest-Growing Geographies in the #Which Factors and External Forces Are Driving Demand in the Cell & Gene Therapy Manufacturing Services Market?# Market?
North America was the largest region in the cell and gene therapy manufacturing services market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global cell & gene therapy manufacturing services market report forecast period. The regions covered in the cell & gene therapy manufacturing services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Which Cutting-Edge Market Trends Are Expected to Drive theCell & Gene Therapy Manufacturing Services Market’s Growth?
Rapid advancements in technology constitute a crucial trend increasing traction in the cell and gene therapy manufacturing services sector. To stay competitive, leading companies in this field are embracing cutting-edge technologies. For instance, a pharmaceutical firm from the United States renowned for its preclinical, clinical labs, gene and cell therapies – Charles River Laboratories International Inc. – in October 2022, launched an innovation named the navigation Vector Platform (navigation). This platform streamlines the route to GMP Adeno-Associated Virus (AAV) vector manufacturing, eliminating the need for comprehensive process development. The navigation platform, in comparison to conventional manufacturing workflows, can reduce the time taken by a program to reach GMP by 55% for viral vector gene therapy researchers. The navigation methodology by Charles River rests on a novel high-yield HEK293 suspension cell line that can be escalated and serotyped based on client requirements.
View the full report here:
What Are the Key Elements That Define the Cell & Gene Therapy Manufacturing Services Market?
Cell and gene therapy manufacturing services refer to the manufacturing and quality-testing services for gene and cell therapy products. It aids in the advancement and production of remedies for degenerative illnesses, tissue injuries, and genetic abnormalities. These services include good manufacturing practices ancillary reagents, flow cytometry, immunoassays, and gene engineering services.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10035
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
